In recent years, the medical beauty industry has become a fast-growing industry in China. In 2015, China's medical beauty market broke through 550 billion yuan for the first time, with an annual growth rate of nearly 20%. It is expected that the industry scale will reach 100 billion yuan in 2019, which is expected to surpass Brazil and become the world. The second largest medical beauty market. In 2015, China's medical and beauty market accounted for 34% of the total market size, which is expected to reach 46% in 2019. From the point of view of product sales, injection micro-shaping based on hyaluronic acid is the core driving force for the medical and beauty industry. From the total number of treatments, the proportion of minimally invasive will increase from 67% in 2015 to 75% in 2019.
Modern medical beauty (referred to as "medical beauty") refers to the use of surgery, drugs, medical equipment and other traumatic or invasive medical techniques to repair and reshape human appearance and various parts of the human body, thereby enhancing A scientific, technical, and artistic medical science for the purpose of aesthetics outside the human body.
Medical beauty is a medical service and a consumer product. Once accepted by consumers, the pursuit of beauty will accompany consumers for a lifetime. In particular, the emergence of micro-shaping blurs the boundaries between “whole†and “beautyâ€. The consumption cycle covers from the youngsters to the “knowing the destinyâ€, but the people of different ages have different types of products. The 20-year-old focuses on contouring, the 30-year-old focuses on freckle whitening and postpartum repair, and the 40-year-old focuses on anti-aging wrinkles.
At present, injection micro-plastics, such as hyaluronic acid, have gradually become the core driving force for the rapid development of the medical and aesthetic industry. According to the data of “New Oxygen 2016 White Paperâ€, in 2016, 10 million hyaluronic acids were sold in regular hospitals nationwide. According to Liu Xin, the new oxygen COO, hyaluronic acid accounted for 26% of all orders. At present, a total of 13 hyaluronic acid products have been approved by the State Food and Drug Administration, including 4 imported brands and 9 domestic brands.
At present, the industrial chain of China's medical and beauty industry can be roughly divided into five modules. The upstream pharmaceutical and equipment manufacturers produce the corresponding drugs, injections and equipment, and flow through the agents to the medical and aesthetic institutions. Users obtain institutional information through various promotion methods and choose Appropriate medical institutions to seek medical care. At this stage, there are four main types of plastic surgery institutions in China, namely public hospitals, private large chain hospitals, private small and medium-sized clinics, and private doctors' clinics.
Medical beauty belongs to high-end consumption, and consumers are groups with certain economic strength. According to data released by the American Plastic Surgery Association in 2015, the age of consumers in the US medical industry is concentrated between 19 and 64 years old, with a proportion of 88.1%, among which women are mostly women. According to the National Bureau of Statistics, the number of females aged 20-64 in China reached 445 million in 2015, while the total number of women in the world's largest medical beauty industry in the United States was only 162 million. At present, the penetration rate of medical beauty in China is still low. The average number of plastic surgery according to the population base is still far from the developed countries in the medical beauty industry. The potential customer group is broad and the future development space is broad.
Tremella Fuciformis Extract,Edible mushrooms polysaccharide,Tremella Polysaccharide,White Tremella Extract
Shaanxi Zhongyi Kangjian Biotechnology Co.,Ltd , https://www.zhongyibiology.com